Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Luckhaus

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
European Journal of Neurology|April 8, 2009
Cerebral grey and white matter changes in mild cognitive impairment and Alzheimer's diseaseC Luckhaus
The International Journal of Neuropsychopharmacology|May 10, 2001
Venlafaxine withdrawal syndrome not prevented by maprotiline, but resolved by sertralineC Luckhaus, C Jacob
American Journal of Medical Genetics|December 20, 2000
MAO-B gene intronic dinucleotide repeat polymorphism revisitedP G Sand, C Luckhaus
Der Nervenarzt|September 15, 2018
[Oxytocin in schizophrenia : Evidence for an etiological and therapeutic relevance of the social neuromodulator]C Luckhaus, G Juckel, R Hurlemann
Journal of Neural Transmission (Vienna, Austria : 1996)|July 12, 2002
Untangling the human estrogen receptor gene structureP Sand, C Luckhaus, K Schlurmann, et al.
Molecular Psychiatry|October 26, 2006
Clozapine enhances differentiation of adipocyte progenitor cellsK Hemmrich, C Gummersbach, N Pallua, et al.
Fortschritte Der Neurologie-Psychiatrie|August 9, 2014
[Pilot study on a modular outpatient treatment programme following public order placements because of endangerment in patients with psychotic disorders]C Luckhaus, N Kampka, N Frommann, et al.
Pharmacopsychiatry|May 19, 2015
Reversible Amisulpride-induced Elevation of Creatine Kinase (CK): A Case Series from the German AMSP Pharmacovigilance ProjectZ G Laoutidis, A Konstantinidis, R Grohmann, et al.
Neurobiology of Disease|April 13, 2001
Alzheimer's disease-like alterations in peripheral cells from presenilin-1 transgenic miceA Eckert, K Schindowski, S Leutner, et al.
Biochimica Et Biophysica Acta|December 13, 2000
Hippocampal level of neural specific adenylyl cyclase type I is decreased in Alzheimer's diseaseM Yamamoto, M E Götz, H Ozawa, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
European Journal of Neurology|April 8, 2009
Cerebral grey and white matter changes in mild cognitive impairment and Alzheimer's diseaseC Luckhaus
The International Journal of Neuropsychopharmacology|May 10, 2001
Venlafaxine withdrawal syndrome not prevented by maprotiline, but resolved by sertralineC Luckhaus, C Jacob
American Journal of Medical Genetics|December 20, 2000
MAO-B gene intronic dinucleotide repeat polymorphism revisitedP G Sand, C Luckhaus
Der Nervenarzt|September 15, 2018
[Oxytocin in schizophrenia : Evidence for an etiological and therapeutic relevance of the social neuromodulator]C Luckhaus, G Juckel, R Hurlemann
Journal of Neural Transmission (Vienna, Austria : 1996)|July 12, 2002
Untangling the human estrogen receptor gene structureP Sand, C Luckhaus, K Schlurmann, et al.
Molecular Psychiatry|October 26, 2006
Clozapine enhances differentiation of adipocyte progenitor cellsK Hemmrich, C Gummersbach, N Pallua, et al.
Fortschritte Der Neurologie-Psychiatrie|August 9, 2014
[Pilot study on a modular outpatient treatment programme following public order placements because of endangerment in patients with psychotic disorders]C Luckhaus, N Kampka, N Frommann, et al.
Pharmacopsychiatry|May 19, 2015
Reversible Amisulpride-induced Elevation of Creatine Kinase (CK): A Case Series from the German AMSP Pharmacovigilance ProjectZ G Laoutidis, A Konstantinidis, R Grohmann, et al.
Neurobiology of Disease|April 13, 2001
Alzheimer's disease-like alterations in peripheral cells from presenilin-1 transgenic miceA Eckert, K Schindowski, S Leutner, et al.
Biochimica Et Biophysica Acta|December 13, 2000
Hippocampal level of neural specific adenylyl cyclase type I is decreased in Alzheimer's diseaseM Yamamoto, M E Götz, H Ozawa, et al.
Pageof 2